Literature DB >> 9650334

Risk factors of stroke at high and low altitude areas in Saudi Arabia.

A al Tahan1, J Buchur, F el Khwsky, A Ogunniyi, S al-Rajeh, E Larbi, A Daif, E Bamgboye.   

Abstract

BACKGROUND: The epidemiology of stroke at different geographical locations in the Kingdom of Saudi Arabia has not been adequately investigated.
METHODS: In this study, clinical types and risk factors of stroke were compared among patients at low-altitude (Riyadh, 620 m) and high-altitude (Al Baha > 2000 m) areas using a case-control study design. One-hundred ninety recently diagnosed cases (109 from Riyadh and 81 from Al Baha) were verified and subjects were interviewed. An equal number of age- and sex-matched controls from the corresponding areas were also interviewed using a specific standard questionnaire.
RESULTS: The frequency of thrombotic stroke at high altitude was 93.4% as compared to 79.3% at low altitude (P < 0.05). The odds ratios (OR) for the different risk factors at high and low altitudes, respectively, were: hypertension 4.4 and 2.1; diabetes mellitus: 2.7 and 1.9; ischemic heart disease (IHD): 2.4 and 1.9; atrial fibrillation: 3.9 and 3.3, and smoking: 2.3 and 2.5. The mean hematocrit values were 45.3% at high altitude and 41.0% for low altitude patients (P < 0.001) and its association with stroke at high altitude remained significant even after adjusting for age, gender and occupation.
CONCLUSIONS: The study's finding of an increased frequency of thrombotic stroke at high altitude was explained by increased hematocrit which might have caused this in conjunction with other factors such as hypertension and IHD. Larger studies are recommended for better clarification of interaction between high altitude and other established risk factors not included in this study, such as sickle cell anemia and congenital heart diseases in young patients.

Entities:  

Mesh:

Year:  1998        PMID: 9650334

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  7 in total

1.  Prevalence of coronary risk factors, clinical presentation, and complications in acute coronary syndrome patients living at high vs low altitudes in Yemen.

Authors:  Mohamed Ali Al-Huthi; Yahia Ahmed Raja'a; Mohammed Al-Noami; Abdul Rashid Abdul Rahman
Journal:  MedGenMed       Date:  2006-11-07

2.  Normoxic low-altitude simulation (at 714 mmHg) improves limb blood perfusion in mice with hindlimb ischemia.

Authors:  Anmol Shahid; Trevor H Stenson; Michael S Mcmurtry
Journal:  Physiol Rep       Date:  2021-01

3.  Population-based stroke incidence estimates in Peru: Exploratory results from the CRONICAS cohort study.

Authors:  Maria Lazo-Porras; Antonio Bernabe-Ortiz; Robert H Gilman; William Checkley; Liam Smeeth; J Jaime Miranda
Journal:  Lancet Reg Health Am       Date:  2021-10-30

4.  Influence of Acute Normobaric Hypoxia on Hemostasis in Volunteers with and without Acute Mountain Sickness.

Authors:  Marc Schaber; Veronika Leichtfried; Dietmar Fries; Maria Wille; Hannes Gatterer; Martin Faulhaber; Philipp Würtinger; Wolfgang Schobersberger
Journal:  Biomed Res Int       Date:  2015-09-15       Impact factor: 3.411

5.  A retrospective observational study of functional outcomes, length of stay, and discharge disposition after an inpatient stroke rehabilitation program in Saudi Arabia.

Authors:  Saad M Bindawas; Hussam Mawajdeh; Vishal Vennu; Hisham Alhaidary
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

6.  Molecular genetic studies in Saudi population; identified variants from GWAS and meta-analysis in stroke.

Authors:  Khalid Khalaf Alharbi; Imran Ali Khan; Mohammad Abdullah Alotaibi; Abdullah Saud Aloyaid; Haifa Abdulaziz Al-Basheer; Naelah Abdullah Alghamdi; Raid Saleem Al-Baradie; A M Al-Sulaiman
Journal:  Saudi J Biol Sci       Date:  2017-08-24       Impact factor: 4.219

Review 7.  Recommendations for traveling to altitude with neurological disorders.

Authors:  Marika Falla; Guido Giardini; Corrado Angelini
Journal:  J Cent Nerv Syst Dis       Date:  2021-12-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.